Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Diabetic Ketoacidosis (DKA) Market Growth Evolved From 2024 To 2025, And What’s Ahead?
In recent years, the market size for diabetic ketoacidosis (DKA) has seen significant growth. It is projected to rise from $2.9 billion in 2024 to hit $3.15 billion in 2025, equating to a compound annual growth rate (CAGR) of 8.5%. The ascension during the historical period can be accredited to factors like an amplified prevalence of diabetes, late detection of type 1 diabetes, non-compliance with insulin therapy, a surge in obesity rates, and a dearth of educational programs regarding diabetes.
There’s a predicted robust surge in the size of the diabetic ketoacidosis (dka) market in the coming years, with predictions forecasting a rise to$4.34 billion in 2029. This is linked to a compound annual growth rate (CAGR) of 8.4 percent. Various factors contributing to this growth over the projected period include advancements in the systems used for insulin delivery, an increased acceptance of continuous glucose monitoring, enhanced understanding of diabetes-related health issues, the widening scope of telemedicine for handling diabetes, and an increment in healthcare spending. The forecast period is expected to witness major advancements such as the incorporation of artificial intelligence in diabetes treatment, the creation of closed-loop systems for insulin delivery, the rise of individualized medicine, utilization of advanced technologies, and the introduction of innovative treatment methods.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21168&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Diabetic Ketoacidosis (DKA) Market?
The escalating incidence of obesity is fueling the growth of the diabetic ketoacidosis (DKA) market. Obesity is a health condition characterized by an excess accumulation of body fat that can harm health and boost the likelihood of various illnesses. The rise in obesity is attributed to several factors such as diets laden with processed foods, sugars, and fats, reduced physical activity, increased time spent on screens, and social-economic aspects including access to economically feasible healthful food and healthcare. Higher rates of obesity escalate the danger of diabetic ketoacidosis (DKA), promoting insulin resistance and the onset of type 2 diabetes which can result in inadequate blood sugar regulation and subsequent DKA incidents. For example, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, declared that around one in eight people globally were grappling with obesity. This included 2.5 billion adults (18 years and older) who were overweight, amongst which 890 million were living with obesity. In terms of adults, 43% were overweight, and 16% were categorized as obese. Furthermore, the quantity of overweight children under the age of 5 peaked at 37 million. Thus, the growing prevalence of obesity is propelling the expansion of the diabetic ketoacidosis market.
Which Key Market Segments Comprise the Diabetic Ketoacidosis (DKA) Market and Drive Its Revenue Growth?
The diabetic ketoacidosis (dka)market covered in this report is segmented –
1) By Type: Pediatric Diabetic Ketoacidosis, Adult Diabetic Ketoacidosis
2) By Treatment Type: Fluid Replacement, Electrolyte Replacement, Insulin Therapy, Intermediate-Acting Insulin, Long-Acting Insulin
3) By Route of Administration: Oral, Parenteral, Other
4) By Distribution Channel: Online Channel, Offline Channel
5) By End Use: Hospitals, Ambulatory Care Center, Specialty Clinics
Subsegments:
1) By Pediatric Diabetic Ketoacidosis: Mild Pediatric DKA; Moderate Pediatric DKA; Severe Pediatric DKA
2) By Adult Diabetic Ketoacidosis: Mild Adult DKA; Moderate Adult DKA; Severe Adult DKA
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21168&type=smp
Which Areas Are Leading Regions in the Diabetic Ketoacidosis (DKA) Market Expansion Across the Globe?
North America was the largest region in the diabetic ketoacidosis (DKA) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic ketoacidosis (DKA) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theDiabetic Ketoacidosis (DKA) Market Over the Coming Years?
The primary players in the diabetic ketoacidosis arena are concentrating their efforts on the creation of pioneering technologies, including continuous glucose monitoring tools, in an effort to enhance early diagnosis, effectively control blood sugar and ketone levels, and ultimately decrease the frequency and harshness of DKA events among diabetics. Continuous glucose monitor (CGM) instruments are gadgets that constantly measure glucose levels in the body, providing immediate data to help diabetics maintain stable blood sugar levels. Take for example, Abbott Laboratories, a medical device company based in the US, who in June 2022, introduced cutting-edge continuous glucose-ketone monitoring systems to offer real-time tracking of both glucose and ketone levels. This system synchronizes the real-time monitoring of both glucose and ketones, thereby offering an all-inclusive perspective on a patient’s metabolic status. The simultaneous measurement of glucose and ketones facilitates the early discovery of possible diabetic complications like diabetic ketoacidosis (DKA) prior to them reaching a critical stage. This system is engineered for uninterrupted monitoring, offering users convenient and regular data updates without the necessity for manual examinations.
View the full report here:
https://www.thebusinessresearchcompany.com/report/diabetic-ketoacidosis-dka-global-market-report
How Is the Diabetic Ketoacidosis (DKA) Market Conceptually Defined?
Diabetic ketoacidosis (DKA) refers to a serious diabetes complication where the body produces high levels of blood acids called ketones, often due to insufficient insulin, leading to dehydration, electrolyte imbalances, and potentially life-threatening conditions. They are used for diagnosing and managing severe metabolic imbalances in diabetic patients to prevent complications such as dehydration, organ failure, and coma.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21168
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model